CJC-1295 (No DAC) / Ipamorelin Blend is a synthetic peptide combination designed to act on growth hormone regulatory pathways involved in endocrine signaling, metabolism, and physiological homeostasis. This laboratory reference material is primarily intended for analytical and scientific research applications only. It is not intended for human consumption, diagnostic use, or therapeutic application outside of regulated pharmaceutical development.
CJC-1295 (No DAC) is a modified growth hormone-releasing hormone (GHRH) analog that interacts with GHRH receptors, while Ipamorelin is a selective ghrelin (growth hormone secretagogue) receptor agonist. Together, this dual-peptide blend is engineered to support investigation of growth hormone release through complementary receptor pathways. These signaling mechanisms are involved in endocrine regulation, pulsatile growth hormone secretion, and downstream metabolic processes. In experimental settings, this blend has been studied in receptor signaling models and peptide interaction research.
Specifications:
Purity: High-purity, typically ≥98% by HPLC
Form: Lyophilized powder
Storage: Store at -20 °C or colder, protected from light and moisture
Solubility: Soluble in sterile water, buffered saline solutions, or other aqueous laboratory solvents
Usage: Intended for laboratory research, receptor binding assays, endocrine pathway studies, and cellular biology investigations
Important Notice:
This product is for analytical research purposes only and must not be used for human or animal consumption, diagnostic procedures, or therapeutic applications. Handle using appropriate laboratory safety protocols and equipment, and ensure compliance with all applicable regulations governing research materials.
